Indefinite Delivery Contract SPM2DX14D0981

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The single-award IDC, valued up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring needs of military health facilities worldwide under the SPE2DB program. The contract includes firm fixed-price delivery orders for common medications like antibiotics and pain relievers, as well as specialized drugs, biologics, and medical consumables to support the diverse medical requirements of the Department of Defense (DoD) and Department of Veterans Affairs (VA).

Through this IDC, DMS Pharmaceutical Group supplies a variety of critical and routine pharmaceutical items, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. These products are primarily delivered to the DLA's Medical Supply Chain division, which then distributes them to various DoD healthcare facilities globally. The contract has no set-aside designations and leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for the federal pharmaceutical supply chain. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical market.